A two-step synthesis sequence furnishes quadruply annulated borepins in high yields. The first step involves a nucleophilic substitution reaction between aryl-BFK salts (aryl = mesityl, phenyl) and lithiated bromonapthalene derivatives LiNaph (HNaph = 8-bromonaphthalene (a), 5-bromoacenaphthene (b), 5-bromoacenaphthylene (c)). In the second step, the resulting heteroleptic triarylboranes aryl-B(Naph) (3a-c) are subjected to an intramolecular Ni-mediated Yamamoto reaction to close the seven-membered rings and create the borepins 4a-c. Only in the case of 3b is the Yamamoto reaction accompanied by a C-H activation reaction furnishing the 7-hydro-7-borabenzo[de]anthracene derivative 5. The product ratio 4b/5 can be influenced by control of the local Ni(0) concentration. The borepins 4a-c are benchtop stable and highly soluble even in hexane. Compounds 4a-c undergo reversible one-electron reduction; 4c is also able to accept a second electron in a reversible manner and already at moderate potential values (E = -1.49 V and -1.84 V (vs FcH/FcH)). 4a, 4b, and 5 show photoluminescence in the blue-green region of the spectrum, while 4c is nonfluorescent, which is likely attributable to an intramolecular charge-transfer transition.
The high-yield synthesis of a boron-doped [4]helicene was achieved through a Ni-mediated Yamamoto C-C-coupling reaction; the moderate distortion of the molecular scaffold confers excellent solubility to the air- and water-stable green luminophore.
Depending on the solvent, a brominated arylborane gave the multiple helicene B2-TBPA (pyridine) or the oxadiborepin ODBE (THF) after intramolecular Yamamoto coupling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.